Severe adverse drug reaction in SARS‐CoV‐2 infection: AGEP induced by ceftriaxone and confirmed by patch test.

Keywords: AGEP/TEN overlap; ceftriaxone; COVID-19; patch test; SARS-CoV-2 infection; severe cutaneous adverse reaction EN AGEP/TEN overlap ceftriaxone COVID-19 patch test SARS-CoV-2 infection severe cutaneous adverse reaction 366 368 3 08/16/21 20210901 NES 210901 Adverse drug reactions (ADRs) are rarely reported in patients with coronavirus disease 2019 (COVID-19) despite the wide range of medications administered to slow the progression of the disease and relieve symptoms caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). AGEP/TEN overlap, ceftriaxone, COVID-19, patch test, SARS-CoV-2 infection, severe cutaneous adverse reaction Severe adverse drug reaction in SARS-CoV-2 infection: AGEP induced by ceftriaxone and confirmed by patch test. [Extracted from the article]